What is the purpose of an 'Orphan Drug' designation?
Show answer and explanation
Correct answer: To encourage the development of drugs for rare diseases affecting a small portion of the population
The Orphan Drug Act provides incentives, such as tax credits and extended market exclusivity, for pharmaceutical companies to develop treatments for rare diseases. These diseases are defined in the US as affecting fewer than 200,000 people.
Keep practicing
More Clinical Trials questions
- An 'Intent-to-Treat' (ITT) analysis is used in clinical trials to:
- Which regulatory document must be submitted to the FDA before a drug can begin Phase I human testing?
- What does the term 'Placebo Effect' refer to in the context of clinical trials?
- A 'Single-Blind' study is most commonly used when:
- Which of the following is an example of a 'Surrogate Endpoint' in a clinical trial?
- In the context of drug development, what is a 'Lead Compound'?